[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2009/29384,2009,A2Locationinpatent:Page/Pagecolumn91
1195782-19-4 
 
100368-29-4 
 
76-05-1 
 
13-cyclohexyl-3-methoxy-N-(1-methylethyl)sulfonyl-6-1-(1-methyl-4-piperidinyl)-4-(3-oxa-9-azabicyclo3.3.1non-9-ylcarbonyl)-1H-pyrazol-5-yl-7H-indolo2,1-a2benzazepine-10-carboxamidetrifluoroacetate 
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2009/280083,2009,A1Locationinpatent:Page/Pagecolumn14-15
1195782-36-5 
 
100368-29-4 
 
76-05-1 
 
13-cyclohexyl-N-(isopropylsulfonyl)-3-methoxy-6-(1-(3-methyl-4-pyridinyl)-4-(3-oxa-9-azabicyclo3.3.1non-9-ylcarbonyl)-1H-pyrazol-5-yl)-7H-indolo2,1-a2benzazepine-10-carboxamidetrifluoroacetate 
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2009/280083,2009,A1Locationinpatent:Page/Pagecolumn21-22
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2009/280083,2009,A1Locationinpatent:Page/Pagecolumn78-79
lithium4-(((R)-2-((S)-2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-2-hydroxyethyl)carbamoyl)benzoate 
 
100368-29-4 
 
C31H39N3O6 
[1]CurrentPatentAssignee:CANCERTHERAPEUTICSCRCPTYLTD-WO2016/34673,2016,A1Locationinpatent:Page/Pagecolumn179-180